share_log

Autolus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.03%),Deep Track Biotechnology Master Fund, Ltd.(9.03%), etc.

Autolus Therapeutics | SC 13G:超过5%持股股东披露文件-Deep Track Capital, LP(9.03%),Deep Track Biotechnology Master Fund, Ltd.(9.03%)等

2022/12/19 16:11
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息